Somewhat Favorable News Coverage Somewhat Unlikely to Affect Envision Healthcare (EVHC) Stock Price

News headlines about Envision Healthcare (NYSE:EVHC) have been trending somewhat positive this week, Accern reports. The research group identifies positive and negative media coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Envision Healthcare earned a news impact score of 0.07 on Accern’s scale. Accern also gave news headlines about the company an impact score of 46.1378044820597 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Here are some of the news headlines that may have effected Accern’s rankings:

A number of equities research analysts have commented on EVHC shares. Robert W. Baird restated a “buy” rating and set a $70.00 target price on shares of Envision Healthcare in a research note on Tuesday, October 17th. SunTrust Banks set a $55.00 target price on shares of Envision Healthcare and gave the stock a “buy” rating in a research note on Sunday, October 15th. Bank of America decreased their target price on shares of Envision Healthcare from $72.00 to $60.00 and set a “buy” rating on the stock in a research note on Monday, October 9th. KeyCorp set a $67.00 target price on shares of Envision Healthcare and gave the stock a “buy” rating in a research note on Wednesday, November 1st. Finally, Jefferies Group set a $71.00 target price on shares of Envision Healthcare and gave the stock a “buy” rating in a research note on Wednesday, November 1st. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and nine have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $40.73.

Envision Healthcare (EVHC) traded up $0.28 during mid-day trading on Monday, hitting $36.11. 1,911,513 shares of the company were exchanged, compared to its average volume of 2,525,343. Envision Healthcare has a 1 year low of $23.77 and a 1 year high of $73.00. The company has a debt-to-equity ratio of 0.89, a quick ratio of 3.00 and a current ratio of 3.01. The stock has a market capitalization of $4,330.00, a price-to-earnings ratio of -24.23, a PEG ratio of 0.94 and a beta of 0.57.

Envision Healthcare (NYSE:EVHC) last posted its earnings results on Tuesday, October 31st. The company reported $0.73 earnings per share for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.08). Envision Healthcare had a negative net margin of 6.39% and a positive return on equity of 4.88%. The business had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $2.03 billion. During the same period last year, the business posted $1.13 earnings per share. The company’s revenue for the quarter was up 142.0% compared to the same quarter last year. research analysts anticipate that Envision Healthcare will post 2.49 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece was first reported by TrueBlueTribune and is the property of of TrueBlueTribune. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright legislation. The correct version of this piece can be viewed at

Envision Healthcare Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Insider Buying and Selling by Quarter for Envision Healthcare (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply